S&P also affirmed its “AA/A-1+” rating on NorthShore University HealthSystem’s series 1995 and series 2001C bonds, and its “AA/A-1” rating on the health system’s series 1996 and 2001B bonds.
The short-term rating is a result of upcoming expirations of bond purchase agreements from JPMorgan Chase Bank and Wells Fargo Bank. The rating also reflects $75 million of unrated commercial paper expiring November 2019.
The outlook was revised to stable from positive.
“The outlook revision reflects our view of NorthShore as it faces systematic challenge in the face of the changing health care landscape,” said Brian Williamson, an S&P Global Ratings credit analyst.
More articles on healthcare finance:
29 hospital, health system outlook and credit rating actions in July
Fitch: Failed ACA replacement efforts add to healthcare sector uncertainty
California implements balance billing rules: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
